021-5137-0935
sales@aqbiopharma.com.cn
Aqbiopharma was founded in 2007 as one of China’s early enterprises specializing in the dedicated R&D of fluorinated new drugs and fluorinated pharmaceutical intermediates.
The company operates a 2,800 m² R&D and pilot testing center and a 51 mu industrial production base. After nearly 20 years of continuous investment and technological research, we have developed more than 3,000 mass-producible products. Multiple core process technologies and new drug research achievements have been filed for invention patents, with a total of 30 patents granted.
Our main products cover a full range of fluorinated pharmaceutical intermediates, including heterocyclic fluorine building blocks such as piperidine, piperazine, pyrrolidine, azaindole, adamantane, aza-spirocycles and aza-fused rings.
We have established business and strategic cooperation with over 800 customers at home and abroad, including leading global biopharmaceutical companies, world-renowned research institutes and universities. Our self-developed technologies and products also support our in-house new drug R&D programs.
The company has been awarded the titles of National High-tech Enterprise, Specialized, Refined, Unique and Innovative SME, and National Innovative SME. It has also obtained more than ten provincial and national research projects including the Innovative Fund for Technology-based SMEs sponsored by the Ministry of Science and Technology, Shanghai Pujiang Talent Program, and Science and Technology Support Program of Jiangsu Provincial Department of Science and Technology.
We have obtained certifications of ISO9001 Quality Management System, ISO14001 Environmental Management System and ISO45001 Occupational Health and Safety Management System.
